Zhengye Biotechnology Holding Limited Accounts Receivable, Allowance for Credit Loss, Current
Zhengye Biotechnology Holding Limited (ZYBT) had Accounts Receivable, Allowance for Credit Loss, Current of CNY 18.03 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-04-28
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current 18.03M CNY.
- 2025-06-30: Accounts Receivable, Allowance for Credit Loss, Current 16.16M CNY.
- 2024-12-31: Accounts Receivable, Allowance for Credit Loss, Current 16.87M CNY.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss, Current 18.62M CNY.
CNY
| Period end | Accounts Receivable, Allowance for Credit Loss, Current |
|---|---|
| 2025-12-31 | 18.03M CNY 20-F · filed 2026-04-28 |
| 2025-06-30 | 16.16M CNY 6-K · filed 2025-12-12 |
| 2024-12-31 | 16.87M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 18.62M CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 21.38M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2025-12-31 | $2.58M 20-F · filed 2026-04-28 | |
| 2025-06-30 | $2.26M 6-K · filed 2025-12-12 | |
| 2024-12-31 | $2.41M 20-F · filed 2026-04-28 | $2.31M 20-F · filed 2025-07-03 |
| 2023-12-31 | $2.55M 20-F · filed 2025-07-03 |